Scarica l'app Stockscreener
97.75
1.78%
-1.77
Pre-mercato:
97.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$99.52
Aprire:
$99.53
Volume 24 ore:
206.34K
Relative Volume:
0.80
Capitalizzazione di mercato:
$2.23B
Reddito:
$256.28M
Utile/perdita netta:
$62.40M
Rapporto P/E:
36.02
EPS:
2.7139
Flusso di cassa netto:
$79.12M
1 W Prestazione:
+0.45%
1M Prestazione:
-13.34%
6M Prestazione:
+11.17%
1 anno Prestazione:
+23.55%
Intervallo 1D:
$97.58
$99.55
Intervallo di 1 settimana:
$97.50
$103.23
Portata 52W:
$78.35
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Nome
Lemaitre Vascular Inc
Settore
Industria
Telefono
781-221-2266
Indirizzo
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
97.75 | 2.27B | 256.28M | 62.40M | 79.12M | 2.7139 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Iniziato | Wells Fargo | Equal Weight |
| 2024-10-15 | Iniziato | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Ripresa | Lake Street | Buy |
| 2024-05-31 | Ripresa | ROTH MKM | Buy |
| 2024-04-26 | Aggiornamento | Stifel | Hold → Buy |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-06 | Iniziato | Oppenheimer | Outperform |
| 2023-08-03 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Iniziato | Jefferies | Buy |
| 2021-02-12 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Aggiornamento | Sidoti | Neutral → Buy |
| 2019-10-24 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Aggiornamento | Lake Street | Hold → Buy |
| 2019-10-14 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Reiterato | Barrington Research | Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Ripresa | ROTH Capital | Buy |
| 2018-04-26 | Downgrade | Stifel | Buy → Hold |
| 2018-04-26 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Downgrade | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Iniziato | First Analysis Sec | Overweight |
| 2017-02-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Downgrade | Sidoti | Buy → Neutral |
| 2016-07-28 | Reiterato | Barrington Research | Outperform |
| 2016-02-25 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
(LMAT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular to join two major healthcare investor conferences in June - Pluang
LeMaitre to Participate at Upcoming Investor Conferences in June - The Manila Times
LeMaitre schedules June talks at Jefferies and Goldman healthcare events - Stock Titan
GSA Capital Partners LLP Has $1.72 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Three Healthcare Stocks Facing Potential Headwinds in 2026 - IndexBox
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124 - Moomoo
Q3 2025 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
Wakefield Asset Management LLLP Buys New Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call - Yahoo Finance
LeMaitre Vascular stock (US52567J1079): Q1 beat and raised 2026 guidance - AD HOC NEWS
[SCHEDULE 13G/A] LEMAITRE VASCULAR INC Amended Passive Investment Disclosure - Stock Titan
LeMaitre Vascular Senior Vice President of Operations Trent Kamke Sells 44% Of Holding - Moomoo
(LMAT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Why LeMaitre Vascular (LMAT) Is Down 10.9% After Raising 2026 Guidance And Boosting Dividends - simplywall.st
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120 - 富途牛牛
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround - Yahoo Finance
LeMaitre Vascular Inc (NASDAQ:LMAT): A Quality Investing Candidate Passing All Caviar Cruise Screen Tests - ChartMill
Insider Transaction: George LeMaitre Sells $5.03M Worth Of LeMaitre Vascular Shares - Benzinga
LeMaitre Vascular stock (US52567J1079): Insiders sell amid recent price drop - AD HOC NEWS
Vanguard Group Inc. Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Lemaitre Vascular Insider Sold Shares Worth $5,032,413, According to a Recent SEC Filing - Moomoo
Insider Sell: Trent Kamke Sells Shares of LeMaitre Vascular Inc (LMAT) - GuruFocus
Lemaitre Vascular senior V.P. Kamke sells $313k in stock - Investing.com UK
Bridget Ross Sells 5,044 Shares of LeMaitre Vascular (NASDAQ:LMAT) Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Trent Kamke Sells 2,928 Shares - MarketBeat
LeMaitre Vascular CEO George LeMaitre sells $5.03m in stock By Investing.com - Investing.com Nigeria
LeMaitre Vascular CEO George LeMaitre sells $5.03m in stock - Investing.com
LeMaitre Vascular(LMAT.US) Officer Sells US$5.03 Million in Common Stock - Moomoo
LeMaitre Vascular (LMAT) CEO sells 46,481 shares, retains over 1.4M - Stock Titan
Lemaitre Vascular director Lawrence J Jasinski sells $433,730 in stock By Investing.com - Investing.com Australia
Lemaitre Vascular director Lawrence J Jasinski sells $433,730 in stock - Investing.com UK
Lemaitre Vascular senior V.P. Kamke sells $313k in stock By Investing.com - Investing.com Canada
LeMaitre (LMAT) senior VP sells 2,928 shares in open-market trade - Stock Titan
Lemaitre Vascular Insider Sold Shares Worth $433,730, According to a Recent SEC Filing - Moomoo
LeMaitre Vascular (LMAT) director exercises options and sells 5,044 shares - Stock Titan
LeMaitre Vascular (LMAT) director exercises options, then sells 3,943 shares - Stock Titan
LeMaitre outlines 2026 targets including $280M revenue and $3 EPS as international Artegraft expands - MSN
LMAT (NASDAQ) restricted stock vesting noted; Trent G. Kamke sold shares under Rule 144 - Stock Titan
Number of shareholders of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
LeMaitre Vascular Is Maintained at Equal-Weight by Wells Fargo - Moomoo
LeMaitre to Present at the Bank of America Healthcare Conference - The Manila Times
LeMaitre management takes Bank of America conference stage May 13 - Stock Titan
LeMaitre Vascular declares $0.25 dividend - MSN
[144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan
Proposed LMAT common-stock sale by Morgan Stanley (LMAT) reported 05/07/2026 - Stock Titan
Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):